Stage | Method | Recommendation |
---|---|---|
Pre-analytical | Sampling | Freeze samples at − 80 °C (or at least − 20 °C) as soon as possible within a standardized time range for all samples. We suggest within 1 h |
Pre-analytical | Centrifugation | Centrifuge samples to eliminate circulating cells or debris under standardized settings (speed, temperature), using the same centrifuge if possible. We suggest 2000g, at 20–25 °C for 15 min |
Pre-analytical | Hemolysis detection | Inspect presence of hemolysis by spectrophotometric absorbance at 414Â nm, or by monitoring qPCR miR ratio between miR23a and miR 451a |
Pre-analytical | Carrier | Use a carrier during RNA extraction, for fluids expected to contain low levels of miRNAs (such CSF, serum, urine). We suggest MS2 phage RNA carrier |
Pre-analytical | cDNA synthesis | Perform 2–3 replicates for each RNA stock to detect possible inhibitors carried over from RNA isolation |
Pre-analytical | Spike-in | Use an exogenous miRNAs (e.g. Cel-miR-39a) to add prior to RNA isolation or cDNA synthesis to assess technical performance |
Pre-analytical | Primers | Re-design primers with PCR efficiencies outside the range of 80–110% |
Analytical | Normalization | For normalization, several miRNAs should be tested for stability between controls and disease samples using suitable software algorithms, for example GeNorm and/or NormFinder. We recommend using two or more miRNAs for normalization if possible |
Analytical | Statistics | Normal distributed data: use parametric test (e.g. t-test, ANOVA) Data not normal distributed: use non-parametric test (e.g. Mann–Whitney test) Apply more complex model (seek professional statistical assistance) if the model has several confounding variables (gender, age, etc.) Correct P values for multiple testing |